ArticleData in brief2022
Benchmark data set for breast cancer associated genes.
Article in Data in brief, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 5 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is one of the leading causes of death in women worldwide. The main reason could be inheritance, change in environmental conditions or the mutation in certain genes that cause cancer. These genes are not negligible, on the contrary, a wide range of genes have their involvement in the development and progression of different stages of breast cancer. In this article, we are going to explore the association of breast cancer genes and classify them into different association classes viz. positive, negative and neutral. Among all the available biomedical literature resources for a disease, HuGE Navigator is a major resource comprising continually updated human genome epidemiology data controlled by the Centers for Disease Control and Prevention. However the literature finder module of HuGE Navigator only yields PubMed IDs for a specific disease, which are explored further to retrieve abstract data from PubMed. These abstracts are filtered out to include those reference sentences which have at least one gene and disease term. This reference sentence data has been taken as a reference to apply double-fold cross-validation to compile the most comprehensive list and then classify them into different association classes viz, positive, negative or neutral along with the reference sentences confirming the association of the disease with the gene. The positively associated data generated here can be used for breast cancer modelling or meta-analysis of breast cancer. The data generated in the present work can be used as standard reference data for the training of text mining-based biological literature classifiers to predict the class of published literature not only in breast cancer but in other diseases as well.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.